Last reviewed · How we verify
Liberal blood pressure management
At a glance
| Generic name | Liberal blood pressure management |
|---|---|
| Sponsor | Miodrag Filipovic, Prof. Dr. med. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Restrictive Fluid Management In Liver Transplantation (REFIL) (NA)
- Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP) (PHASE4)
- Effect of Giving Reduced Fluid in Children After Trauma (NA)
- Fluid Therapy and Glycocalyx Shedding During Moderate Surgery (NA)
- Hemodynamic Optimization During Spinal Anesthesia in the Elderly
- Intraoperative Different Fluid Therapy Protocols (NA)
- Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (PHASE3)
- Goal Directed Fluid Therapy Versus Liberal Fluid Regimen in Primary Elective Hip Artrhoplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: